GridAI Technologies (GRDX) Exchange Rate Effect (2015 - 2022)
GridAI Technologies' (GRDX) quarterly Exchange Rate Effect came in at -$226045.0 in Q4 2022, down 397.39% on a YoY basis from $76010.0 in Q4 2021, and down 3965.34% quarter-over-quarter from $5848.0 in Q3 2022.
Powered by 
Analysis
GridAI Technologies (GRDX) Exchange Rate Effect (2015 - 2022) Analysis & Trends
GridAI Technologies (GRDX) has reported Exchange Rate Effect for 8 consecutive years, with -$226045.0 the latest figure, recorded in Q4 2022.
- For the quarter ending Q4 2022, Exchange Rate Effect fell 397.39% year-over-year to -$226045.0; the trailing twelve-month figure through Dec 2022 stood at -$259713.0 (down 944.43% YoY), and the FY2025 full-year result was $204751.0, changed N/A from the prior year.
- Exchange Rate Effect retreated to -$226045.0 in Q4 2022 per GRDX's latest filing, from $5848.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $76010.0 in Q4 2021 and bottomed at -$226045.0 in Q4 2022.
- Historically, Exchange Rate Effect has averaged -$13846.7 across 5 years, with a median of -$6166.5 in 2018.
- The sharpest annual moves came in 2019 and 2020: Exchange Rate Effect slumped 2809.67% in 2019, then surged 468.92% in 2020.
- Over 5 years, Exchange Rate Effect stood at $29469.0 in 2018, then slumped by 57.9% to $12406.0 in 2019, then tumbled by 576.47% to -$59111.0 in 2020, then surged by 228.59% to $76010.0 in 2021, then slumped by 397.39% to -$226045.0 in 2022.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$226045.0, $5848.0, and -$30747.0 for Q4 2022, Q3 2022, and Q2 2022 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -19.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | -3.70 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | -300,000.00 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -2.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -3.40 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 315,000.00 |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -226,045.00 |
| Sep 30, 2022 | 5,848.00 |
| Jun 30, 2022 | -30,747.00 |
| Mar 31, 2022 | -8,769.00 |
| Dec 31, 2021 | 76,010.00 |
| Sep 30, 2021 | 4,940.00 |
| Jun 30, 2021 | -36,456.00 |
| Mar 31, 2021 | -13,738.00 |
| Dec 31, 2020 | -59,111.00 |
| Sep 30, 2020 | 20,423.00 |
| Jun 30, 2020 | 19,523.00 |
| Mar 31, 2020 | -6,423.00 |
| Dec 31, 2019 | 12,406.00 |
| Sep 30, 2019 | -6,562.00 |
| Jun 30, 2019 | -5,292.00 |
| Mar 31, 2019 | -26,478.00 |
| Dec 31, 2018 | 29,469.00 |
| Sep 30, 2018 | -5,910.00 |
| Jun 30, 2018 | -19,112.00 |
| Mar 31, 2018 | -910.00 |